Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test Spinal Cerebral Ataxia (SCA) Type-1 is 14 days.

What are the prerequisites for the test Spinal Cerebral Ataxia (SCA) Type- 1

Prerequisites for Spinal Cerebral Ataxia (SCA) Type-1 Test:

  • Referral from a healthcare provider
  • Symptoms of ataxia, such as unsteady gait, clumsiness, and difficulty with coordination
  • Family history of SCA Type-1 or other types of ataxia
  • Physical examination by a neurologist
  • Neurological tests, such as MRI or CT scans, to rule out other possible causes of ataxia
  • Blood tests to check for genetic mutations associated with SCA Type-1

What are the measure values for the test Spinal Cerebral Ataxia (SCA) Type- 1

  • Repeat expansion of CAG trinucleotide in the ATXN1 gene
  • Normal: 6-44 repeats
  • Intermediate: 45-49 repeats
  • Full penetrance: ≥50 repeats
  • Reduced penetrance: 36-39 repeats

What does this test Spinal Cerebral Ataxia (SCA) Type- 1 identify?

This test for Spinal Cerebellar Ataxia (SCA) Type-1 identifies the presence of a specific genetic mutation known as SCA1. This mutation affects the function of the cerebellum, the part of the brain responsible for coordinating movement and balance.

Individuals with SCA1 may experience symptoms such as unsteadiness, clumsiness, and difficulty with coordination. The test looks for the presence of the abnormal gene associated with SCA1, which can help to confirm a diagnosis and guide treatment options.

Why is this test Spinal Cerebral Ataxia (SCA) Type- 1 taken?

Spinal Cerebellar Ataxia (SCA) Type-1 test is taken to diagnose a rare genetic disorder that affects the nervous system. This test is usually recommended if an individual is experiencing symptoms such as uncoordinated movement, difficulty with balance and coordination, slurred speech, and tremors.

The test for SCA Type-1 involves genetic testing to look for mutations in the ATXN1 gene, which is responsible for causing the disorder. By identifying these mutations, doctors can confirm a diagnosis of SCA Type-1 and provide appropriate treatment and management strategies for the patient.

No FAQs available.

Customer Google Rating